Sionna Therapeutics, Inc.
SION · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | -$62 | -$47 | -$40 |
| Dep. & Amort. | $1 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $2 | $2 |
| Change in WC | -$3 | -$1 | $3 |
| Other Non-Cash | $8 | $2 | -$0 |
| Operating Cash Flow | -$53 | -$44 | -$36 |
| Investing Activities | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$2 |
| Net Acquisitions | $0 | $0 | $0 |
| Inv. Purchases | -$183 | -$24 | -$40 |
| Inv. Sales/Matur. | $56 | $52 | $13 |
| Other Inv. Act. | $0 | $0 | $0 |
| Investing Cash Flow | -$127 | $27 | -$29 |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | $0 |
| Stock Issued | $179 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $111 |
| Financing Cash Flow | $179 | $0 | $111 |
| Forex Effect | $0 | $0 | $0 |
| Net Chg. in Cash | -$1 | -$16 | $46 |
| Supplemental Information | – | – | – |
| Beg. Cash | $39 | $56 | $10 |
| End Cash | $39 | $39 | $56 |
| Free Cash Flow | -$53 | -$45 | -$38 |